The Gulf conflict has disrupted global supply chains, pushed...
REITs have changed the way commercial real estate is owned a...
What really powers the cloud? Behind every Google search, A...
What really powers the cloud? Behind every Google search, A...
Luxury real estate is one of the most talked-about segments ...
Kwality Pharmaceuticals Ltd has acquired 4 acres of land in Amritsar, Punjab, to develop a fully automated pharmaceutical manufacturing facility. The planned unit will have four injectable dosage lines and more than six oral dosage lines. The company is targeting completion of the project by the fourth quarter of the 2027–28 financial year, with full operations expected to begin in the second quarter of FY2028–29. The facility will expand the company's manufacturing infrastructure, although the reported announcement does not specify the project's investment cost or expected production capacity.
Kwality Pharmaceuticals Ltd has acquired 4 acres of land in Amritsar, Punjab, to build a fully automated pharmaceutical manufacturing facility with four injectable dosage lines and more than six oral dosage lines. The project is targeted for completion by the fourth quarter of FY2027–28, with full operations expected to begin in the second quarter of FY2028–29, according to a Reuters report.
The planned facility will include production lines for injectable medicines and oral dosage products. Injectable medicines are administered through methods such as injections, while oral dosage products include medicines taken by mouth, such as tablets and capsules.
Kwality Pharmaceuticals manufactures pharmaceutical formulations and operates from its existing facility in Nag Kalan on Majitha Road in Amritsar. The company also has a manufacturing unit in Himachal Pradesh. Its existing product portfolio includes injectable and oral solid dosage formulations.
The new facility is expected to add to the company's manufacturing infrastructure. However, the reported announcement does not specify the project's investment cost, proposed production capacity or the number of jobs it could create.
The company is targeting completion by Q4 FY2027–28, followed by the start of full operations in Q2 FY2028–29. These timelines indicate that the facility is planned to become operational after construction and installation of its manufacturing systems are completed.
The proposed facility will add another manufacturing asset to Kwality Pharmaceuticals' operations in Punjab. Its progress will depend on construction, equipment installation and the steps required before commercial production begins. The number of dosage lines provides an indication of the planned production setup, but the absence of disclosed capacity and investment figures limits the assessment of the project's expected scale. The company's progress against its stated completion and operational targets will be important developments to track.
Source Reuters
17th Nov, 2026
17th Nov, 2026
17th Nov, 2026
17th Nov, 2026
17th Nov, 2026